ABVC vs. ELAB, AKTX, ERNA, AVTX, MIRA, MBRX, MTEM, KPRX, GHSI, and MNPR
Should you be buying ABVC BioPharma stock or one of its competitors? The main competitors of ABVC BioPharma include Elevai Labs (ELAB), Akari Therapeutics (AKTX), Eterna Therapeutics (ERNA), Avalo Therapeutics (AVTX), MIRA Pharmaceuticals (MIRA), Moleculin Biotech (MBRX), Molecular Templates (MTEM), Kiora Pharmaceuticals (KPRX), Guardion Health Sciences (GHSI), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical preparations" industry.
ABVC BioPharma (NASDAQ:ABVC) and Elevai Labs (NASDAQ:ELAB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.
ABVC BioPharma and Elevai Labs both received 0 outperform votes by MarketBeat users.
In the previous week, ABVC BioPharma had 1 more articles in the media than Elevai Labs. MarketBeat recorded 5 mentions for ABVC BioPharma and 4 mentions for Elevai Labs. ABVC BioPharma's average media sentiment score of 0.52 beat Elevai Labs' score of -0.03 indicating that ABVC BioPharma is being referred to more favorably in the media.
Elevai Labs has a net margin of 0.00% compared to ABVC BioPharma's net margin of -6,919.08%. Elevai Labs' return on equity of 0.00% beat ABVC BioPharma's return on equity.
11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 22.2% of Elevai Labs shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Elevai Labs has higher revenue and earnings than ABVC BioPharma.
Summary
Elevai Labs beats ABVC BioPharma on 6 of the 10 factors compared between the two stocks.
Get ABVC BioPharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ABVC BioPharma Competitors List
Related Companies and Tools
